References
Zetter BR: The cellular basis of site specific tumor metastasis. NEJM 322: 605–612, 1990
Abercrombie: The crawling movement of metazoan cells. Proc R Soc Lond (Biol) 207: 129–147, 1980
Hosaka S, Suzuki M, Goto M, Sato H: Motility of rat ascites hepatoma cells, with reference to malignant characteristics in cancer metastasis. Gann 69: 273–276, 1978
Raz A, Ben-Ze'ev A: Cell contact and architecture of malignant cells and their relationship to metastasis. Cancer Metastasis Rev 6: 3–21, 1987
Mohler JL, Partin AW, Coffey DS: Prediction of metastatic potential by a new grading system of cell motility: validation in the Dunning R-327 prostatic adenocarcinoma model. J Urol 138: 168–170, 1987
Partin NW, Isaacs JT, Trieger B, Coffey DS. Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with V-Harvey-ras oncogene. Cancer Res 48: 6050–6053, 1988
Aznavoorian SA, Stracke ML, Krutzsch H, Schiffman E, Liotta LA: Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells. J Cell Biol 110: 1427–1438, 1990
McCarthy JB, Hager SJ, Furcht LTF: Human fibronectin contains distinct adhesion-and motility promoting domains for metastatic melanoma cells. J Cell Biol 102: 179–188, 1986
Mensing H, Albini A, Krieg T, Pontz BF, Muller PK: Enhanced chemotaxis of tumor-derived and virus-transformed cells to fibronectin and fibroblast conditioned medium. Int J Cancer 33: 43–48, 1985
McCarthy JB, Basara ML, Palm SL, Sas DF, Furcht LT: The role of cell adhesion proteins laminin and fibronectin in the movement of malignant and metastatic cells. Cancer Met Rev 4: 125–152, 1985
Yusa T, Blood CM, Zetter BR: Tumor cell interactions with elastin: implications for pulmonary metastasis. Am Rev Respir Dis 140: 1458–1462, 1989
Gherardi E, Gray M, Stoker M, Perryman M, Fulong R: Proc Natl Acad Sci USA 86: 5844–5848, 1989
Rosen EM, Meromsky L, Setter E, Vinter DW, Goldberg ID: Quantitation of cytokine stimulated migration of endothelium and epithelium by a new assay using microcarrier beads. Exp Cell Res 186: 22–31, 1990
Stoker M, Gherardi E, Perryman M, Grey J: Scatter factor is a fibroblast derived modulator of epithelial cell mobility. Nature 327: 239–242, 1987
Atnip KD, Carter LM, Nicolson GL, Dabbous MK: Chemotactic response of rat mammary adenocarcinoma cell clones to tumor derived cytokines. Biochem Biophys Res Comm 146: 996–1002, 1987
Liotta LA, Mandler R, Murano G, Katz DA, Gordon RK, Chiang FPK, Schiffmann E. Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 83: 3302–3306, 1986
Yoshida K, Ozaki T, Ushijina K, Hayashi H: Studies on the mechanisms of invasion in cancer. I. Isolation and purification of a factor chemotactic for cancer cells. Int J Cancer 6: 123–132, 1970
Schor SL, Schor AM, Grey AM, Rushton G: Foetal and cancer patient fibroblasts produce an autocrine migration stimulating factor not made by normal adult cells. J Cell Sci 90: 391–399, 1988
Stracke ML, Engel JD, Wilson LW, Rjechler MM, Liotta LA, Schiffman JE. The type 1 IGF receptor is a motility receptor in human melanoma cells. J Biol Chem 264: 21544–21549.
Rights and permissions
About this article
Cite this article
Turley, E. Molecular mechanisms of cell motility. Cancer Metast Rev 11, 1–3 (1992). https://doi.org/10.1007/BF00047598
Issue Date:
DOI: https://doi.org/10.1007/BF00047598